HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).

AbstractBACKGROUND AND PURPOSE:
Although inorganic arsenite (As(III)) is toxic in humans, it has recently emerged as an effective chemotherapeutic agent for acute promyelocytic leukemia (APL). In humans and most animals, As(III) is enzymatically methylated in the liver to weakly toxic dimethylarsinic acid (DMAs(V)) that is a major pentavalent methylarsenic metabolite. Recent reports have indicated that trivalent methylarsenicals are produced through methylation of As(III) and participate in arsenic poisoning. Trivalent methylarsenicals may be generated as arsenical-glutathione conjugates, such as dimethylarsinous glutathione (DMAs(III)G), during the methylation process. However, less information is available on the cytotoxicity of DMAs(III)G.
EXPERIMENTAL APPROACH:
We synthesized and purified DMAs(III)G using high performance TLC (HPTLC) methods and measured its cytotoxicity in rat liver cell line (TRL 1215 cells).
KEY RESULTS:
DMAs(III)G was highly cytotoxic in TRL 1215 cells with a LC(50) of 160 nM. We also found that DMAs(III)G molecule itself was not transported efficiently into the cells and was not cytotoxic; however it readily became strongly cytotoxic by dissociating into trivalent dimethylarsenicals and glutathione (GSH). The addition of GSH in micromolar physiological concentrations prevented the breakdown of DMAs(III)G, and the DMAs(III)G-induced cytotoxicity. Physiological concentrations of normal human serum (HS), human serum albumin (HSA), and human red blood cells (HRBC) also reduced both the cytotoxicity and cellular arsenic uptake induced by exposure to DMAs(III)G.
CONCLUSIONS AND IMPLICATIONS:
These findings suggest that the significant cytotoxicity induced by DMAs(III)G may not be seen in healthy humans, even if DMAs(III)G is formed in the body from As(III).
AuthorsT Sakurai, C Kojima, Y Kobayashi, S Hirano, M H Sakurai, M P Waalkes, S Himeno
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 149 Issue 7 Pg. 888-97 (Dec 2006) ISSN: 0007-1188 [Print] England
PMID17043674 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Arsenicals
  • Arsenites
  • Serum Albumin
  • dimethylarsinous acid
  • darinaparsin
  • Cacodylic Acid
  • Glutathione
Topics
  • Animals
  • Antineoplastic Agents (adverse effects, metabolism)
  • Arsenic Poisoning (metabolism)
  • Arsenicals (chemical synthesis, metabolism)
  • Arsenites (adverse effects, metabolism)
  • Cacodylic Acid (analogs & derivatives, chemistry, metabolism, toxicity)
  • Cell Line
  • Cell Survival (drug effects)
  • Chromatography, Thin Layer (methods)
  • Dose-Response Relationship, Drug
  • Erythrocytes
  • Glutathione (analogs & derivatives, chemical synthesis, chemistry, metabolism, pharmacology, toxicity)
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Inhibitory Concentration 50
  • Methylation
  • Rats
  • Rats, Inbred F344
  • Serum Albumin (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: